Skip to main content

BioWisdom Joins $14.5M European Alzheimer Biomarker Project

NEW YORK, May 4 (GenomeWeb News) - Cambridge, UK-based BioWisdom said today that it will join the AddNeuroMed project of the European Commission's Innovative Medicines for Europe consortium, where it will use its Sofia software platform to help identify and validate Alzheimer's disease biomarkers.
 
BioWisdom said it will receive direct funding for its work, but it did not disclose financial details.
 
The INNOMED consortium of about 40 commercial and academic groups is led by the European Federation of Pharmaceutical Industries and Associations.
 
The consortium is sponsored by the EC under its Sixth Framework Program, which will provide about €11.5 million ($14.5 million) over three years, the statement added.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.